Saturday, November 15, 2014 | 11:00 AM - 4:00 PM
Moderators: Florian Jehle (Catenion), Jan-Philipp Kruse (Catenion)
This course gives professionals from inside and outside the pharmaceutical industry—including students and postdocs—a much better understanding of how the R&D and business development and licensing processes operate.
Monday, May 19, 2014 | 7:00 PM - 8:30 PM
Keynote Speakers: Ernst Fehr (University of Zurich), Rolf Pfeifer (University of Zurich)
While we may think of our intelligence and ability to make choices as properties of the human brain, insights from the fields of artificial intelligence and economics paint a more complicated picture. Join two experts in the field to learn more!
Wednesday, October 30, 2013 | 3:00 PM - 8:00 PM
Moderator: Florian Jehle (Partner, Catenion)
This course gives professionals from inside and outside the pharmaceutical industry- including students and postdocs- a much better understanding of how the R&D and business development and licensing processes operate.
Monday, April 15, 2013 | 8:00 AM - 5:00 PM
Speakers: Bruce Kingma (iSchool and Whitman, Syracuse University), Rajit Manohar (Cornell NYC Tech), James Spencer (Rensselaer Polytechnic Institute)
This conference will examine programs in NY State’s universities which are building the professional infrastructure needed to support NY's innovation economy and will explore future public partnerships on human capital development.
Tuesday, December 11, 2012 | 6:30 PM - 8:00 PM
Paul Zak (Claremont Graduate University)
What makes some people nice and others nasty? Is there chemistry behind our morality? Join neuroeconomist Paul Zak to hear how our chemistry plays a large role in why some of us relate to Mr. Rogers more than Gordon Gekko. Part of the Science and the Seven Deadly Sins Series.
Edited by Annals of the New York Academy of Sciences
This Annals volume presents four reports: (1) Alzheimer's Disease Research and Development: a Call for a New Research Roadmap; (2) Economic Analysis of Opportunities to Accelerate Alzheimer's Disease Research and Development; (3) Nanomedicines: Addressing the Scientific and Regulatory Gap; and (4) The Science and Policy of Critical Loads of Pollutant Deposition to Protect Ecosystems in New York.
Edited by Maureen M. Black
(University of Maryland School of Medicine, Baltimore, Maryland) and Kathryn G. Dewey
(University of California, Davis, California)
International experts in nutrition and childhood development discuss the current status of integrating early childhood interventions
Keynote Speaker: David B. Allison (University of Alabama at Birmingham)
Perhaps the most disturbing facet of the rise in obesity worldwide is the rise in childhood obesity. This eBriefing features researchers, physicians, teachers, and other professionals at the front lines of the childhood obesity epidemic who met in Bimghamton, NY to discuss this alarming public health problem.
This eBriefing highlights research and policy work discussed at the Qatar Foundation Annual Research Forum. Topics include cultures of entrepreneurship, scientific publishing, innovation in the Arab world, knowledge-based economies, structures of R&D enterprises, regional and global partnerships, and much more.
With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.
According to the New York City Panel on Climate Change, global warming could have a big impact on the five boroughs. Three experts discuss the Panel's recent findings, and tell us what weather and policy changes to expect.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.